Navigation Links
Helix BioPharma Corp. announces management changes
Date:11/15/2007

AURORA, ON, Nov. 15 /PRNewswire-FirstCall/ - Helix BioPharma Corp. (TSX, FSE: "HBP") today announced position changes for Dr. Donald Segal and John Docherty. Effective immediately, the joint role of Chief Executive Officer and President formerly held by Dr. Segal will be separated whereby Dr. Segal will remain the Company's Chief Executive Officer and Mr. Docherty will assume the role of President.

"These changes are being made as we strive to expand our corporate initiatives, primarily in the U.S.A.," said Dr. Segal. "Moving forward, I am pleased to have John take on added responsibilities so that I may increasingly focus my time on growing our business by developing new financial, partnering and other strategic initiatives for the Company. John will concentrate on enhancing our public profile, overseeing our advancing clinical programs and managing our related day to day operations."

Dr. Segal and Mr. Docherty have a history of proven leadership with the Company. Dr. Segal is a founding partner, serves on the board of directors and had been Chief Executive Officer and President since 2004. Mr. Docherty joined the Company in 1999 with degrees in toxicology and pharmacology and a comprehensive background in pharmaceutical product and corporate development. At Helix, Mr. Docherty has been instrumental in developing the Company's lead product candidate, Topical Interferon Alpha-2b, in addition to supporting the Company's growing investor and media relations initiatives. Previously, Mr. Docherty served as Vice President, Corporate Development since 2002.

About Helix BioPharma Corp.

Helix BioPharma Corp. is a biopharmaceutical company specializing in the field of cancer therapy. The Company is actively developing innovative products for the prevention and treatment of cancer based on its proprietary technologies. Helix's product development initiatives include its Topical Interferon Alpha-2b and its novel L-DOS47 new drug candidate. Helix
'/>"/>

SOURCE Helix BioPharma Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor
2. Helix BioPharma Chairman resigns
3. Helix BioPharma Corp. announces fiscal 2007 results
4. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
5. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
6. PDL BioPharma Announces Internal CEO Investigation Found No Credible Evidence of Improper Personal Conduct or Breach of Fiduciary Duty
7. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
8. PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development
9. XTL Biopharmaceuticals Announces Presentation of Novel Pre-Clinical Inhibitors of Hepatitis C at an Upcoming International Scientific Conference
10. XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain
11. Nabi Biopharmaceuticals Announces Sale of Nabi Biologics to Biotest AG
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Md. , Dec. 24, 2014  United ... today that Medtronic, Inc. (NYSE: MDT ... the U.S. Food and Drug Administration (FDA) for ... implantable drug infusion system (including a newly developed ... (treprostinil) Injection delivered intravenously to patients with ...
(Date:12/24/2014)... 2014   BioLife Solutions , Inc. (NASDAQ: ... of proprietary clinical grade hypothermic storage and ... shipping products for cells and tissues  ("BioLife" or ... 2015 Annual Meeting of Stockholders on May 4, 2015 ... for the Annual Meeting represents a change of more ...
(Date:12/24/2014)... MA (PRWEB) December 23, 2014 Earlier ... Dr. James L. Sherley, director of the Adult Stem ... on an often overlooked and under appreciated unique property ... Self-Renewal by Distributed Stem Cells: Misunderstood in the Past, ... message to congress participants. He gave the address ...
(Date:12/24/2014)... According to Ross Selinger, President of Selinger ... the national office market continues to be strong, driven by ... by the third quarter’s surprising 3.9% GDP, unemployment decreasing to ... have held inflation down and the Fed is keeping interest ... remaining soft. , This solid economic news is having a ...
Breaking Biology Technology:United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4BioLife Solutions Sets Date for Annual Meeting of Stockholders 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4ITRA Global Reports Long Island Is Out of Sync With The National Office Market 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 3
... Pearl Therapeutics was named by FierceBiotech today as one ... of the most promising private biotechnology companies in the industry. ... "Pearl,s veteran team has done a super job of raising ... an inhaled LAMA/LABA combination therapy – toward the market," says ...
... 6, 2011 The anonymity of egg donors is a ... but a spot survey of some donors suggests its removal ... In a survey of its egg donor base ... and gestational surrogacy recruitment firm, over 90 percent of respondents ...
... Calif., Sept. 6, 2011 /PRNewswire-Asia/ -- The Journal of ... 30 patients with Hereditary Ataxia showed statistically significant improvements ... with a combination of cord blood-derived stem cell treatments ... conducted at the Nanshan Affiliated Hospital of Guangdong Medical ...
Cached Biology Technology:FierceBiotech Names Pearl Therapeutics a 2011 Fierce 15 Biotech 2FierceBiotech Names Pearl Therapeutics a 2011 Fierce 15 Biotech 3Egg Donor Anonymity Not Critical, Spot Survey by Agency Suggests 2New Study Finds Cord Blood-derived Stem Cell Treatments Improve Ataxia Patients' Functionality and Quality of Life 2
(Date:12/3/2014)... Ariz. , Dec. 2, 2014 As ... hand readers, Inception Technologies is pleased to announce the ... easier for customers to collect the workforce data that ... problems that have been left by existing readers. Many ... user interface, connectivity and modern technology. Older models force ...
(Date:11/21/2014)... Nov. 20, 2014 Strict laws against distracted ... piloting the North American and European automotive sector towards ... gesture recognition systems that are intuitive and able to ... the industry. New analysis from Frost ... Market in Europe and ...
(Date:11/18/2014)... 2014  The Secure Identity & Biometrics Association ... announce the formation of The Airport Entry and ... Identity and Biometric Entry and Exit Solutions Framework ... support from BORDERPOL, the international non-profit organization that ... expertise regarding border security, traveler and migration systems. ...
Breaking Biology News(10 mins):Inception Technologies to Release New Biometric Reader 2Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 2Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 4Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 3
... fluxes in carbon sequestration, and other forest ecosystem functions. ... collected woody plant traits. Yet, the traditional method to ... have developed a new, resourceful way to take repeated ... are metal straps that wrap around a tree trunk ...
... Research Careers) Program has announced the travel award recipients ... at the Marine Biological Laboratory in Woods Hole, MA ... students, postdocs and new assistant professors who aspire to ... application. This year MARC conferred 15 awards totaling $15,000. ...
... Michigan researchers and their University of Hawaii colleagues say ... into open-ocean fish, and their findings suggest that levels ... rise in coming decades. Using isotopic measurement techniques ... 80 percent of the toxic form of mercury, called ...
Cached Biology News:New technique for measuring tree growth cuts down on research time 2New technique for measuring tree growth cuts down on research time 3Mercury levels in Pacific fish likely to rise in coming decades 2Mercury levels in Pacific fish likely to rise in coming decades 3Mercury levels in Pacific fish likely to rise in coming decades 4
Quantibody Human Angiogenesis Array 1 (1 slide) Class: Quantitative Antibody Arrays Product Group: Antibody Array...
Vertical Rack (five box vapor phase rack), includes 2.0" (5.1cm) boxes...
... 1-D PAGE Cleavable ICAT ... Targeted Protein ID and ... Gel Electrophoresis (PAGE), isotope-coded ... cleavable-linker technology to facilitate ...
Conjugate Quality Control Evaluation Specificity: Conjugate Quality Control Evaluation ...
Biology Products: